Drug Index


Mechanism :

Haloperidol is a butyrophenone derivative with antipsychotic properties that has been considered particularly effective in the management of hyperactivity, agitation, and mania. Haloperidol is an effective neuroleptic and has a marked tendency to provoke extrapyramidal effects. The mechanism of action of haloperidol has not been entirely elucidated but has been attributed to the inhibition of the transport mechanism of cerebral monoamines, particularly by blocking the impulse transmission in dopaminergic neurons.

Indication :

  • Schizophrenia, psychosis/sedation
  • Tourette syndrome
  • Intractable hiccup
  • Persistent nausea
  • Behavioural disorders
  • Acute agitation.

Contraindications :

Contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have Parkinson disease. Do not use in patients with known hypersensitivity to phenothiazines.

Dosing :

Schizophrenia, mania and tic disorders, Tourette syndrome:
2-12 years:
25-50 microgram/day (Max: 10 mg/day) and divided into two or three doses.
12-18 years:
0.5-2 mg/day (Max: 60 mg/day) in divided between 2 doses.
Intractable hiccup:
12-18 years-1.5 mg TDS.

Adverse Effect :

Akathisia, Parkinson-like symptoms, dystonia or muscle stiffness, Tardive Dyskinesia, insomnia, anxiety, euphoria, restlessness, agitation, grand mal seizures, drowsiness, depression, lethargy, vertigo, headache, confusion, exacerbation of psychotic symptoms including hallucinations, hyperpyrexia, hyperthermia, neuroleptic malignant syndrome (NMS), weight gain, tachycardia, alteration in the blood pressure, QT prolongation, mild and usually transient leukopenia and leucocytosis, minimal decreases in red blood cell counts, anemia, or a tendency toward lymphomonocytosis, increased liver enzymes or jaundice, maculopapular and acneiform skin reactions, lactation, mastalgia, breast engorgement, oligomenorrhea or dysmenorrhea, impotence, gynecomastia, hyperglycemia, increased libido, anorexia, nausea and vomiting, alteration of bowel habits, hypersalivation, dyspepsia, dry mouth, diaphoresis, blurred vision, priapism, urinary retention, laryngospasm, bronchospasm and hyperpnoea.

Interaction :


Cisapride, Dronedarone, Mifepristone, Pimozide, Potassium Acid Phosphate, Potassium Chloride, Potassium Citrate, Potassium Phosphate, Quinidine (CYP2D6 booster), Thioridazine, Toremifene.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Start with lower doses. For single doses use 100% of normal dose. Accumulation with repeated dosage

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<10 mL/min
HDNot dialysed. Dose as in GFR<10 mL/min
HDF/High fluxNot dialysed. Dose as in GFR<10 mL/min
CAV/VVHDNot dialysed. Dose as in normal renal function

Hepatic Dose :

Haloperidol is extensively metabolized in the liver. it is recommended to halve the initial dose and adjust the dose with smaller increments and at longer intervals than in patients without hepatic impairment.
03/21/2024 00:15:30 Haloperidol
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0